Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma
Clinical trial NCT00019175 · COMPLETED
Trial details
- NCT number
- NCT00019175
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1996-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.